1. Home
  2. AGRO vs VIR Comparison

AGRO vs VIR Comparison

Compare AGRO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adecoagro S.A.

AGRO

Adecoagro S.A.

HOLD

Current Price

$14.04

Market Cap

1.5B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.40

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGRO
VIR
Founded
2002
2016
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
AGRO
VIR
Price
$14.04
$8.40
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$9.33
$19.63
AVG Volume (30 Days)
2.1M
3.5M
Earning Date
03-16-2026
05-06-2026
Dividend Yield
2.53%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$16.27
N/A
Revenue Next Year
$0.06
$1,049.62
P/E Ratio
$37.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.89
$4.16
52 Week High
$14.95
$10.91

Technical Indicators

Market Signals
Indicator
AGRO
VIR
Relative Strength Index (RSI) 70.45 45.05
Support Level $7.67 $5.14
Resistance Level N/A $10.29
Average True Range (ATR) 0.93 0.47
MACD 0.22 -0.18
Stochastic Oscillator 87.30 3.20

Price Performance

Historical Comparison
AGRO
VIR

About AGRO Adecoagro S.A.

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: